0
0
The Food Safety and Standards Authority of India (FSSAI) issued a significant directive on October 14, 2025, banning the use of the term “ORS” (Oral Rehydration Salts or Solution) on all food and beverage product labels, including brand names and trademarks, unless the product strictly complies with the World Health Organization (WHO) approved ORS formula. This move aims to prevent the widespread consumer confusion and health risks caused by misleading products inaccurately marketed as ORS but not meeting the WHO standards.
Previously, FSSAI had allowed some conditional use of the ORS label provided a disclaimer was present clarifying the product was not a WHO-recommended ORS formula. These earlier permissions, issued in 2022 and 2024, have now been withdrawn, indicating a stricter regulatory stance.
The use of ORS branding on non-compliant products misleads consumers, particularly risking children’s health during diarrheal illnesses, by implying rehydration efficacy that the products do not possess. This deceptive labeling violates multiple provisions under the Food Safety and Standards Act, 2006, and is subject to penalties.
The crackdown follows long-standing concerns and legal activism, notably a Public Interest Litigation filed by pediatrician Dr. Sivaranjani Santosh against the sale of sugar-laden beverages falsely claiming to be ORS substitutes. The FSSAI’s directive is a consumer protection measure to ensure only scientifically validated ORS solutions are marketed as such, preserving integrity in public health communication.
Key Developments in FSSAI’s ORS Labeling Directive
-
The FSSAI directive dated October 14, 2025, mandates removal of the term “ORS” from all food and beverage product names unless the formula aligns exactly with WHO-approved ORS composition.
-
Previous orders permitting ORS label use with disclaimers have been revoked effective immediately, tightening regulation.
-
Non-compliance will be actionable under the Food Safety and Standards Act, 2006.
-
Products including fruit-based drinks, non-carbonated beverages, or ready-to-drink fluids cannot use ORS labeling unless meeting WHO standards.
-
FSSAI emphasizes that any use of the term ORS in product branding otherwise is misleading, deceptive, and illegal.
Expert Perspectives and Public Health Context
Dr. Sivaranjani Santosh, a Hyderabad-based pediatrician, spearheaded public interest litigation against misleading ORS substitutes, highlighting how flawed labeling misleads consumers and endangers children suffering from diarrheal diseases, a leading cause of mortality in India. She welcomed FSSAI’s stringent stance as a crucial step in protecting child health.
WHO-approved ORS formulas contain precisely balanced electrolytes and glucose to facilitate effective rehydration in diarrheal illness, a recognized lifesaving treatment. Many branded beverages marketed with the ORS label but lacking the proper formulation pose serious health risks, including inadequate rehydration and potential worsening of the patient’s condition.
Implications for Consumers and Industry
Consumers should ensure that products marketed as ORS follow strict WHO-recommended formulations that provide safe and effective rehydration. Misleading labels increase the risk of improper treatment, especially for vulnerable populations like children.
Food businesses must comply with all FSSAI regulations on labeling and advertising to prevent legal consequences and contribute to truthful consumer information. Removing the ORS term from non-compliant products will help reduce public confusion and protect public health.
Limitations and Counterpoints
-
Trademark and intellectual property debates delayed FSSAI’s prohibition, with some companies opposing restrictions based on established brand names.
-
The directive does not restrict genuine WHO-compliant ORS products from using the label, preserving consumer access to validated formulations.
-
Some critics argue the regulatory environment should balance consumer protection with industry innovation and branding rights, but public health needs remain paramount.
Medical Disclaimer
Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.
References
